id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3293-0007,FDA,FDA-2019-E-3293,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-11-15T05:00:00Z,2023,11,2023-11-15T05:00:00Z,,2023-11-15T18:55:15Z,,0,0,090000648627d24a
FDA-2019-E-3293-0006,FDA,FDA-2019-E-3293,Determination of Regulatory Review Period for Purposes of Patent Extension; MULPLETA,Notice,Determinations,2023-03-22T04:00:00Z,2023,3,2023-03-22T04:00:00Z,2023-05-23T03:59:59Z,2023-03-22T14:59:21Z,2023-05799,0,0,090000648582325d
FDA-2019-E-3293-0005,FDA,FDA-2019-E-3293,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2023-03-09T05:00:00Z,2023,3,2023-03-09T05:00:00Z,,2023-03-09T18:15:52Z,,0,0,0900006485783a34